全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Neuroendocrine Carcinoma of the Cecum

DOI: 10.4236/oalib.1108902, PP. 1-6

Subject Areas: Surgery & Surgical Specialties, Oncology

Keywords: Neuroendocrine Carcinoma, Cecum, Synaptophysin

Full-Text   Cite this paper   Add to My Lib

Abstract

Neuroendocrine carcinoma (NEC) is a malignant tumor with a poor prognosis and can grow at many different sites in the body, but the colon is a very rare site. Clinical Case: We report a case of a 62-year-old man operated on for a tumor of the cecum, which was diagnosed as a high-grade neuroendocrine carcinoma. An immunohistochemical study showed positive marking with synaptophysin. No cancer metastasis was found. Postoperative chemotherapy was applied but the patient died after 8 months of disease progression. Results: The diagnosis of neuroendocrine tumors is often late at the metastasis stage. Colonoscopy identifies most colonic NECs. An abdominal scanner can detect a colonic exophytic mass which is strongly enhanced after the injection of contrast product. The histological appearance is identical to that described in the lung and must be supplemented by an immunohistochemical study. Treatment: No consensus regarding the treatment of colorectal NEC. For localized tumors, surgery associated or not with adjuvant treatment is proposed while chemotherapy is associated or not with radiotherapy. Conclusion: Tumors with locoregional involvement have the best results with resection whenever possible. Optimal management requires a multidisciplinary and systemic approach, and the therapy is limited.

Cite this paper

Krimou, H. , Errabi, N. , Cisse, M. , Kaoukabi, A. E. , Boudhas, A. , Said, B. , Menfaa, M. , Hasbi, S. , Sakit, F. and Choho, A. (2022). Neuroendocrine Carcinoma of the Cecum. Open Access Library Journal, 9, e8902. doi: http://dx.doi.org/10.4236/oalib.1108902.

References

[1]  Kitada, M., Yasuda, S., Abe, M., Takahashi, N., Okazaki, S., Ishibashi, K. and Hayashi, S. (2017) Clinicopathologic Study of Neuroendocrine Carcinoma of the Breast. Journal of Cancer Therapy, 8, 793-799. https://doi.org/10.4236/jct.2017.88069
[2]  Williams, G.T. (2007) Endocrine Tumors of the Gastrointestinal Tract-Selected Topics. Histopathology, 50, 30-41. https://doi.org/10.1111/j.1365-2559.2006.02570.x
[3]  Yasui, O., Tsukamoto, F. and Kudo, K. (2006) Small Cell Undifferentiated Carcinoma of the Ascending Colon with Rapid Enlargement after Resection: Report of a Case and Review of the Literature. The Tohoku Journal of Experimental Medicine, 209, 361-367. https://doi.org/10.1620/tjem.209.361
[4]  Kim, H.C., Park, S.I., Park, S.J., Shin, H.C., Oh, M.H., Kim, H.H., et al. (2005) Small Cell Carcinoma of the Colon: Barium Study and CT Findings. The British Journal of Radiology, 78, 255-256. https://doi.org/10.1259/bjr/36083619
[5]  Dacic, S., Finkelstein, S.D., Baksh, F.K., Swalsky, P.A., Barnes, L.E. and Yousem, S.A. (2002) Small-Cell Neuroendocrine Carcinoma Displays Unique Profiles of Tumor-Suppressor Gene Loss in Relationship to the Primary Site of Formation. Human Pathology, 33, 927-932. https://doi.org/10.1053/hupa.2002.126875
[6]  Stelow, E.B., Moskaluk, C.A. and Mills, S.E. (2006) The Mismatch Repair Protein Status of Colorectal Small Cell Neuroendocrine Carcinomas. The American Journal of Surgical Pathology, 30, 1401-1404. https://doi.org/10.1097/01.pas.0000213272.15221.38
[7]  Naeem, M., Dahiya, M., Clarc, J.I., Creech, S.D. and Alkan, S. (2002) Analysis of c-Kit Protein Expression in Small-Cell Lung Carcinoma and Its Implication for Prognosis. Human Pathology, 33, 1182-1187. https://doi.org/10.1053/hupa.2002.129199
[8]  Hentic, O., Couvelard, A., Rebours, V., Zappa, M., Dokmak, S., Hammel, P., et al. (2011) Ki-67 Index, Tumor Differentiation, and Extent of Liver Involvement Are Independent Prognostic Factors in Patients with Liver Metastases of Digestive Endocrine Carcinomas. Endocrine-Related Cancer, 18, 51-59. https://doi.org/10.1677/ERC-09-0319
[9]  Bierley, J., Gospodarowicz, M.K. and Wittekind, C. (2017) TNM Classification of Malignant Tumors. Wiley-Blackwell, Oxford, UK; Hoboken, NJ.
[10]  Smith, J. and Reidy-Lagunes, D. (2013) The Management of Extrapulmonarypoorly Differentiated (High-Grade) Neuroendocrine Carcinomas. Seminars in Oncology, 40, 100-108. https://doi.org/10.1053/j.seminoncol.2012.11.011
[11]  Klimstra, D.S., Modlin, I.R., Coppola, D., Lloyd, R.V. and Suster, S. (2010) Thepathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging Systems. Pancreas, 39, 707-712. https://doi.org/10.1097/MPA.0b013e3181ec124e
[12]  Anthony, L.B., Strosberg, J.R., Klimstra, D.S., Maples, W.J., et al. (2010) The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs): Well-Differentiated Nets of the Distal Colon and Rectum. Pancreas, 39, 767-774. https://doi.org/10.1097/MPA.0b013e3181ec1261
[13]  Gaffey, M.J., Mills, S.E. and Lack, E.E. (1990) Neuroendocrine Carcinoma of the Colon and Rectum. A Clinicopathologic, Ultrastructural, and Immunohistochemical Study of 24 Cases. The American Journal of Surgical Pathology, 14, 1010-1023. https://doi.org/10.1097/00000478-199011000-00003

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413